Insiders Medicenna Therapeutics Corp.

Equities

MDNA

CA58490H1073

Market Closed - Toronto S.E. Other stock markets 15:59:59 2024-05-09 EDT			5-day change	1st Jan Change
2.77 ^CAD	+5.73%		+16.39%	+559.52%

04-30	Medicenna Therapeutics Corp. announced that it has received CAD 20 million in funding from RA Capital Management, L.P.	CI
04-26	Medicenna Therapeutics Corp. announced that it expects to receive CAD 20 million in funding	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Medicenna Slumps 24% As Reports Nasdaq Delisting, Downsizes Management Team	23-10-27	MT
Medicenna Reports Nasdaq Delisting, Downsizes Management Team	23-10-27	MT
Medicenna Therapeutics Corp. Announces the Departure of Jeff Caravella as Chief Business Officer	23-10-27	CI
Medicenna Brief: Company's listing on the Toronto Stock Exchange will not be impacted	23-10-27	MT
Medicenna Brief: Announcing Nasdaq Delisting and Cutback of Management Team	23-10-27	MT
Medicenna Therapeutics Appoints Humphrey Gardner as Chief Medical Officer	23-10-10	MT
Medicenna Therapeutics Appoints Humphrey Gardner, as Chief Medical Officer	23-10-10	CI
Medicenna Therapeutics Corp. Announces Board Resignations	23-09-28	CI
Medicenna Therapeutics Corp. Announces the Appointment of Jeff Caravella as Chief Financial Officer	23-08-28	CI
Medicenna Appoints Jeff Caravella as Chief Financial Officer	23-08-28	MT
Medicenna Establishing Boston Presence, Appoints Brent Meadows as Chief Business Officer, and Bolsters Management	23-08-14	MT
Medicenna Brief: Establishing Boston Presence, Appointing Brent Meadows as Chief Business Officer, and Bolstering Management	23-08-14	MT
Medicenna Therapeutics Corp. Appoints Brent Meadows as Chief Business Officer	23-08-14	CI
Medicenna Therapeutics Corp. Appoints Dr. Arash Yavari as Chair of Development Advisory Committee	23-08-08	CI
Medicenna on Appointment of Clinical Advisory Board and Dr. Kapil Dhingra as Strategic Advisor; Chief Scientific Officer Departs	22-03-03	MT
Medicenna Therapeutics Corp. Announces Management Changes	22-03-03	CI
Medicenna Therapeutics up 11.3% in US Pre-Market Trading as Forms Scientific Advisory Board	22-01-31	MT
Medicenna Therapeutics Corp. Announces Board Appointments	22-01-31	CI
Medicenna Therapeutics up 12.7% in US Trade, Details Management Change, Appoints Development Advisory Committee	22-01-18	MT
Medicenna Therapeutics Chief Medical Officer Mann Muhsin Steps Down	22-01-18	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Medicenna Therapeutics Corp.

Equities

MDNA

CA58490H1073

Insiders

Filters